posted on 2016-02-25, 00:00authored byAditya S. Vaidya
Histone deacetylases are validated targets for multiple therapeutic applications. Existing histone deacetylase inhibitors have a zinc chelating group, which limits their use due to metabolic instability.The presented work deals with exploration of novel binding sites in histone deacetylase 2 and 8 with photoreactive ligands for the design of histone deacetylase inhibitors without a zinc chelating group.
History
Advisor
Petukhov, Pavel A.
Department
Medicinal Chemistry and Pharmacognosy
Degree Grantor
University of Illinois at Chicago
Degree Level
Doctoral
Committee Member
Thatcher, Gregory R.
Bruzik, Karol S.
van Breemen, Richard B.
Garcia-Martinez, Jesus